Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.

HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation

Open access
Mikulska, Joanna, Juszczyk, Gabriela, Gawrońska-Grzywacz, Monika, Herbet, Mariola·2021·Brain Sciences

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is involved in the pathophysiology of many neuropsychiatric disorders. Increased HPA axis activity can be observed during chronic stress, which plays a key role in the pathophysiology of depression. Overactivity of the HPA axis occurs in major depressive disorder (MDD), leading to cognitive dysfunction and reduced mood. There is also a correlation between the HPA axis activation and gut microbiota, which has a significant impact on the development of MDD. It is believed that the gut microbiota can influence the HPA axis function through the activity of cytokines, prostaglandins, or bacterial antigens of various microbial species. The activity of the HPA axis in schizophrenia varies and depends mainly on the severity of the disease. This review summarizes the involvement of the HPA axis in the pathogenesis of neuropsychiatric disorders, focusing on major depression and schizophrenia, and highlights a possible correlation between these conditions. Although many effective antidepressants are available, a large proportion of patients do not respond to initial treatment. This review also discusses new therapeutic strategies that affect the HPA axis, such as glucocorticoid receptor (GR) antagonists, vasopressin V1B receptor antagonists and non-psychoactive CB1 receptor agonists in depression and/or schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/brainsci11101298

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Regulation of hypothalamic-pituitary-adrenal (HPA) axis activity: stress as a factor activating the HPA axis.
Figure 1 Regulation of hypothalamic-pituitary-adrenal (HPA) axis activity: stress as a factor activating the HPA axis.CC BY · PubMed Central
Figure 2 Activation of the HPA axis including the role of the amygdala, hippocampus and prefrontal cortex. The amygdala stimulates the HPA axis through NE and 5-HT neurotransmission and attenuates the negative feedback exerted by glucocorticoids, leading to a decrease in GRs in the hippocampal area. Glucocorticoids stimulate (through GR) the prefrontal cortex which attenuates the negative feedback to HPA-axis.
Figure 2 Activation of the HPA axis including the role of the amygdala, hippocampus and prefrontal cortex. The amygdala stimulates the HPA axis through NE and 5-HT neurotransmission and attenuates the negative feedback exerted by glucocorticoids, leading to a decrease in GRs in the hippocampal area. Glucocorticoids stimulate (through GR) the prefrontal cortex which attenuates the negative feedback to HPA-axis.CC BY · PubMed Central
Figure 3 HPA axis dysfunction: role of amygdala and hippocampus in neurobiology of depression.
Figure 3 HPA axis dysfunction: role of amygdala and hippocampus in neurobiology of depression.CC BY · PubMed Central
Figure 4 HPA axis in pathomechanisms of depression and schizophrenia: new therapeutic targets affecting the HPA axis.
Figure 4 HPA axis in pathomechanisms of depression and schizophrenia: new therapeutic targets affecting the HPA axis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 246 references

Research works printed but not linked: 2

  1. Kostowski, 2004, Contemporary directions of research on pathomechanism of stress and depression and their importance in shaping views on the effects of antidepressants. Novel studies on stress and depression and their influence on opinions about mechanisms of action of antidepressants, Psychiatry, 1, 63
  2. Gazzaniga, M.S. (2000). The New Cognitive Neurosciences, MIT Press.

Cited by

See all 450

Metadata

Authors
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M.
Affiliations
  • Medical University of Lublin (PL)
  • Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8b Jaczewskiego Street, 20-090 Lublin, Poland
Venue
Brain Sciences
Publisher
MDPI AG
Published
2021-09-30
Volume
11
Issue
10
Pages
1298
ISSN
2076-3425 (ISSN-L)
OpenAlex
W3204457954
Cited by
450
References
246
Citations by year
2026: 108 · 2025: 133 · 2024: 113 · 2023: 62 · 2022: 31 · 2021: 2
FWCI
6.27
Type
journal article
Language
en
Open access
Locations
  • Brain Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
hypothalamic-pituitary-adrenal axis, major depressive disorder, schizophrenia, chronic stress, gut microbiota, cytokines, glucocorticoid receptor antagonist, CB1 receptor agonists, antidepressant resistance, neuropsychiatric disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation. https://app.cochat.ai/papers/10.3390/brainsci11101298
The paper
Mikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021). HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation. Brain Sciences. https://doi.org/10.3390/brainsci11101298

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.